Skip to content

National Survey on the Treatment of Cervical Esophageal Cancer

National Survey on the Treatment of Cervical Esophageal Cancer - National Survey on the Treatment of Cervical Esophageal Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000043783
Enrollment
200
Registered
2021-03-30
Start date
2020-01-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical esophageal cancer

Interventions

None listed

Sponsors

Tokyo Medical and Dental University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: A case of cervical esophageal cancer treated with radical therapy.

Exclusion criteria

Exclusion criteria: Cases in which the larynx was not preserved before treatment. Principle investigators considered inappropriate for eligibility.

Design outcomes

Primary

MeasureTime frame
overall survival

Secondary

MeasureTime frame
larynx preserving rate

Countries

Japan

Contacts

Public ContactKazuchika Ono

Tokyo Medical and Dental University Department of Head and Neck Surgery

ohno.hns@tmd.ac.jp+81-3-5803-5911

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026